Regen BioPharma Inc (RGBP)

[the reaper]

Both Ichims remain in an Advisory capacity. They have added a Former Exec from Eli Lily, Tow from CVS Healthcare to the Board.
HemaXellerate IND# apllied Feb 2013-Approved March 2013
Patient Trials do exiist for HemaXellerate, but the focus moved to a much larger market other than aPlastic Anemia-Focus went to Bone Marrow Supression, Auto Immunes and NR2F6
dCellVax is encompassed also in NR2F6 Oncology/Cancer Patient Trials exist using Patients Own immune systems
BMSN is a different company than RGBP
In the last year two companies were purchased by Bristol Myer Squibb & Eli Lilly-they bought companies with similar programs to RGBP NR2F6 Program. They are/were both about six months to a year ahead of RGBP
Things are progressing Sciientifically just fine
The Shares struggle to move up, you are correct due to more shares maturing/coming due that belong to people that invested. Some do what some or all of their money back after time